PredxBio

Drug Discovery
$2Mtotal raised · 5 rounds on record
$601klatest round · Venture round · Aug 2023 · 3 yr ago
1backers · Keiretsu Forum MENA
1-10team · employees, estimated range

Overview

From tissue biology to oncology decisions. Spatial Medicine connects how cells are organized and interact within tissue to decisions about treatment, patient selection, and drug development.

Funding and backers

Total raised
$2M
5 rounds on record
Latest round
$601k
Venture round · Aug 2023 · 3 yr ago
Team
1-10
employees, estimated range
Backers
1
Keiretsu Forum MENA
The money's age
Long since its last round
39 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 4, 2023 Raised a round Venture round $601k · SEC Form D Jan 27, 2021 Raised a round Venture round $260k · SEC Form D Jul 31, 2020 Raised a round Venture round $463k · SEC Form D Jul 26, 2019 Raised a round Venture round $275k · SEC Form D Aug 24, 2018 Raised a round Venture round $400k · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2023 $601k — SEC Form D
Venture round Jan 2021 $260k — SEC Form D
Venture round Jul 2020 $463k — SEC Form D
Venture round Jul 2019 $275k — SEC Form D
Venture round Aug 2018 $400k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity PredxBio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
B. Dusty MajumdarExecutive Officer, DirectorSEC Form D
Srinivas ChennubhotlaExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Keiretsu Forum MENA fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs AbInitio Bio
Soma Capital
backs Babylon
SOSV
backs FluoSphera SA
Amplify Partners
backs VeriSIM Life
Long Journey Ventures
backs Babylon
Lux Capital
backs Babylon
Similar startupsby what they do, their industry and backers
FluoSphera SA
Advanced 3D and multi-tissue biology for predictive drug discovery. Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker…
AbInitio Bio
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
Babylon
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
Psylink
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
synthbiome
SynthBiome replicating the dynamic nature of human physiology in test tubes for better drug development and treatment selection.
Soricimed51-200 employees
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.

Financials

Total raised
$2M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $601k Details
Venture - Series Unknown 2021 $260k Details
Venture - Series Unknown 2020 $463k Details
Venture - Series Unknown 2019 $275k Details
Venture - Series Unknown 2018 $400k Details

People

B. Dusty Majumdar
Executive Officer, Director
SEC Form D
Srinivas Chennubhotla
Executive Officer, Director
SEC Form D
William Newlin
Director
SEC Form D
Stanley Marks
Director
SEC Form D
D. Lansing Taylor
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Keiretsu Forum MENAVia a fund
22 portfolio companies: smartcells, Telltale, Cardiac Insight and 19 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pittsburgh United States
HQ
1-10 est. staff